nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—CYP3A7—Dapsone—systemic lupus erythematosus	0.0431	0.0841	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0431	0.0841	CbGbCtD
Ziprasidone—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0338	0.0659	CbGbCtD
Ziprasidone—CYP3A5—Dapsone—systemic lupus erythematosus	0.0324	0.0631	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.03	0.0585	CbGbCtD
Ziprasidone—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.03	0.0585	CbGbCtD
Ziprasidone—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0283	0.0553	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0283	0.0553	CbGbCtD
Ziprasidone—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0281	0.0547	CbGbCtD
Ziprasidone—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0225	0.0439	CbGbCtD
Ziprasidone—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0213	0.0415	CbGbCtD
Ziprasidone—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.0187	0.0364	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.0187	0.0364	CbGbCtD
Ziprasidone—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0144	0.0282	CbGbCtD
Ziprasidone—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.014	0.0273	CbGbCtD
Ziprasidone—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.013	0.0254	CbGbCtD
Ziprasidone—HTR2C—choroid plexus—systemic lupus erythematosus	0.0129	0.122	CbGeAlD
Ziprasidone—CYP3A4—Dapsone—systemic lupus erythematosus	0.0126	0.0246	CbGbCtD
Ziprasidone—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0109	0.0213	CbGbCtD
Ziprasidone—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0109	0.0213	CbGbCtD
Ziprasidone—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00939	0.0183	CbGbCtD
Ziprasidone—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00926	0.0181	CbGbCtD
Ziprasidone—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00878	0.0171	CbGbCtD
Ziprasidone—CYP3A4—Prednisone—systemic lupus erythematosus	0.00875	0.0171	CbGbCtD
Ziprasidone—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00859	0.0167	CbGbCtD
Ziprasidone—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00829	0.0162	CbGbCtD
Ziprasidone—HTR2A—choroid plexus—systemic lupus erythematosus	0.00645	0.0614	CbGeAlD
Ziprasidone—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00546	0.0106	CbGbCtD
Ziprasidone—CYP1A2—urine—systemic lupus erythematosus	0.00221	0.021	CbGeAlD
Ziprasidone—HTR2A—urine—systemic lupus erythematosus	0.00173	0.0164	CbGeAlD
Ziprasidone—SLC6A4—blood plasma—systemic lupus erythematosus	0.0017	0.0162	CbGeAlD
Ziprasidone—HTR7—endothelium—systemic lupus erythematosus	0.00163	0.0155	CbGeAlD
Ziprasidone—CYP3A4—urine—systemic lupus erythematosus	0.0016	0.0152	CbGeAlD
Ziprasidone—CYP2D6—urine—systemic lupus erythematosus	0.00157	0.015	CbGeAlD
Ziprasidone—HTR1A—blood plasma—systemic lupus erythematosus	0.00151	0.0144	CbGeAlD
Ziprasidone—HTR7—blood plasma—systemic lupus erythematosus	0.00145	0.0138	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00139	0.0132	CbGeAlD
Ziprasidone—CHRM5—skin of body—systemic lupus erythematosus	0.00131	0.0124	CbGeAlD
Ziprasidone—H1F0—connective tissue—systemic lupus erythematosus	0.00125	0.0119	CbGeAlD
Ziprasidone—H1F0—nephron tubule—systemic lupus erythematosus	0.00121	0.0115	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00119	0.0113	CbGeAlD
Ziprasidone—DRD5—lymphoid tissue—systemic lupus erythematosus	0.00118	0.0112	CbGeAlD
Ziprasidone—HTR1E—nervous system—systemic lupus erythematosus	0.00118	0.0112	CbGeAlD
Ziprasidone—CYP1A2—blood plasma—systemic lupus erythematosus	0.00115	0.011	CbGeAlD
Ziprasidone—HTR1E—central nervous system—systemic lupus erythematosus	0.00113	0.0108	CbGeAlD
Ziprasidone—H1F0—skin of body—systemic lupus erythematosus	0.00113	0.0107	CbGeAlD
Ziprasidone—ADRA1B—kidney—systemic lupus erythematosus	0.00112	0.0107	CbGeAlD
Ziprasidone—CYP3A5—blood plasma—systemic lupus erythematosus	0.00111	0.0106	CbGeAlD
Ziprasidone—H1F0—kidney—systemic lupus erythematosus	0.00106	0.0101	CbGeAlD
Ziprasidone—ADRA2A—blood plasma—systemic lupus erythematosus	0.00106	0.0101	CbGeAlD
Ziprasidone—H1F0—cortex of kidney—systemic lupus erythematosus	0.00103	0.00984	CbGeAlD
Ziprasidone—CHRM4—nervous system—systemic lupus erythematosus	0.00103	0.00983	CbGeAlD
Ziprasidone—HTR2A—endothelium—systemic lupus erythematosus	0.00101	0.00966	CbGeAlD
Ziprasidone—CHRM4—central nervous system—systemic lupus erythematosus	0.000995	0.00947	CbGeAlD
Ziprasidone—HTR1D—connective tissue—systemic lupus erythematosus	0.000966	0.00919	CbGeAlD
Ziprasidone—DRD3—nervous system—systemic lupus erythematosus	0.000961	0.00914	CbGeAlD
Ziprasidone—DRD3—central nervous system—systemic lupus erythematosus	0.000925	0.0088	CbGeAlD
Ziprasidone—HTR6—nervous system—systemic lupus erythematosus	0.000925	0.0088	CbGeAlD
Ziprasidone—H1F0—lymphoid tissue—systemic lupus erythematosus	0.000912	0.00868	CbGeAlD
Ziprasidone—HTR2A—blood plasma—systemic lupus erythematosus	0.000901	0.00858	CbGeAlD
Ziprasidone—DRD5—nervous system—systemic lupus erythematosus	0.0009	0.00857	CbGeAlD
Ziprasidone—HTR6—central nervous system—systemic lupus erythematosus	0.00089	0.00847	CbGeAlD
Ziprasidone—DRD5—central nervous system—systemic lupus erythematosus	0.000867	0.00825	CbGeAlD
Ziprasidone—H1F0—tendon—systemic lupus erythematosus	0.000857	0.00816	CbGeAlD
Ziprasidone—CYP3A4—blood plasma—systemic lupus erythematosus	0.000834	0.00794	CbGeAlD
Ziprasidone—H1F0—bone marrow—systemic lupus erythematosus	0.00083	0.0079	CbGeAlD
Ziprasidone—HTR1D—kidney—systemic lupus erythematosus	0.000822	0.00783	CbGeAlD
Ziprasidone—CYP2D6—blood plasma—systemic lupus erythematosus	0.000821	0.00781	CbGeAlD
Ziprasidone—CHRM5—nervous system—systemic lupus erythematosus	0.000808	0.00769	CbGeAlD
Ziprasidone—CHRM5—central nervous system—systemic lupus erythematosus	0.000778	0.0074	CbGeAlD
Ziprasidone—HTR7—connective tissue—systemic lupus erythematosus	0.00077	0.00732	CbGeAlD
Ziprasidone—H1F0—lung—systemic lupus erythematosus	0.000752	0.00716	CbGeAlD
Ziprasidone—ADRA1B—nervous system—systemic lupus erythematosus	0.000738	0.00702	CbGeAlD
Ziprasidone—HTR3A—lung—systemic lupus erythematosus	0.000717	0.00683	CbGeAlD
Ziprasidone—ADRA1B—central nervous system—systemic lupus erythematosus	0.000711	0.00676	CbGeAlD
Ziprasidone—H1F0—nervous system—systemic lupus erythematosus	0.000697	0.00663	CbGeAlD
Ziprasidone—CHRM3—kidney—systemic lupus erythematosus	0.000688	0.00655	CbGeAlD
Ziprasidone—DRD1—nervous system—systemic lupus erythematosus	0.000688	0.00655	CbGeAlD
Ziprasidone—ADRA2C—nephron tubule—systemic lupus erythematosus	0.000685	0.00652	CbGeAlD
Ziprasidone—H1F0—central nervous system—systemic lupus erythematosus	0.000671	0.00638	CbGeAlD
Ziprasidone—HTR3A—nervous system—systemic lupus erythematosus	0.000664	0.00632	CbGeAlD
Ziprasidone—DRD1—central nervous system—systemic lupus erythematosus	0.000662	0.0063	CbGeAlD
Ziprasidone—HTR7—kidney—systemic lupus erythematosus	0.000655	0.00623	CbGeAlD
Ziprasidone—HTR3A—central nervous system—systemic lupus erythematosus	0.00064	0.00609	CbGeAlD
Ziprasidone—ADRA2C—kidney—systemic lupus erythematosus	0.000602	0.00573	CbGeAlD
Ziprasidone—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.000586	0.00558	CbGeAlD
Ziprasidone—HRH1—connective tissue—systemic lupus erythematosus	0.000575	0.00547	CbGeAlD
Ziprasidone—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000573	0.00546	CbGeAlD
Ziprasidone—ADRA2A—connective tissue—systemic lupus erythematosus	0.000564	0.00537	CbGeAlD
Ziprasidone—HTR1B—nervous system—systemic lupus erythematosus	0.000557	0.0053	CbGeAlD
Ziprasidone—CHRM2—nervous system—systemic lupus erythematosus	0.000554	0.00528	CbGeAlD
Ziprasidone—SLC6A4—lung—systemic lupus erythematosus	0.000547	0.00521	CbGeAlD
Ziprasidone—CHRM1—lung—systemic lupus erythematosus	0.000545	0.00519	CbGeAlD
Ziprasidone—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000543	0.00517	CbGeAlD
Ziprasidone—HTR1D—nervous system—systemic lupus erythematosus	0.00054	0.00514	CbGeAlD
Ziprasidone—HTR1B—central nervous system—systemic lupus erythematosus	0.000537	0.00511	CbGeAlD
Ziprasidone—HTR2C—nervous system—systemic lupus erythematosus	0.000534	0.00509	CbGeAlD
Ziprasidone—CHRM2—central nervous system—systemic lupus erythematosus	0.000534	0.00508	CbGeAlD
Ziprasidone—HTR7—tendon—systemic lupus erythematosus	0.000529	0.00503	CbGeAlD
Ziprasidone—HTR1D—central nervous system—systemic lupus erythematosus	0.00052	0.00494	CbGeAlD
Ziprasidone—HTR2C—central nervous system—systemic lupus erythematosus	0.000514	0.0049	CbGeAlD
Ziprasidone—SLC6A4—nervous system—systemic lupus erythematosus	0.000507	0.00482	CbGeAlD
Ziprasidone—CHRM1—nervous system—systemic lupus erythematosus	0.000505	0.0048	CbGeAlD
Ziprasidone—CYP3A5—kidney—systemic lupus erythematosus	0.000504	0.0048	CbGeAlD
Ziprasidone—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000491	0.00467	CbGeAlD
Ziprasidone—SLC6A4—central nervous system—systemic lupus erythematosus	0.000488	0.00464	CbGeAlD
Ziprasidone—ADRA2C—tendon—systemic lupus erythematosus	0.000486	0.00463	CbGeAlD
Ziprasidone—CHRM1—central nervous system—systemic lupus erythematosus	0.000486	0.00462	CbGeAlD
Ziprasidone—HTR2A—connective tissue—systemic lupus erythematosus	0.00048	0.00457	CbGeAlD
Ziprasidone—KCNH2—bone marrow—systemic lupus erythematosus	0.000477	0.00454	CbGeAlD
Ziprasidone—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000468	0.00445	CbGeAlD
Ziprasidone—HTR7—lung—systemic lupus erythematosus	0.000464	0.00442	CbGeAlD
Ziprasidone—CHRM3—nervous system—systemic lupus erythematosus	0.000452	0.0043	CbGeAlD
Ziprasidone—HTR1A—nervous system—systemic lupus erythematosus	0.00045	0.00428	CbGeAlD
Ziprasidone—DRD2—lung—systemic lupus erythematosus	0.000439	0.00418	CbGeAlD
Ziprasidone—CHRM3—central nervous system—systemic lupus erythematosus	0.000435	0.00414	CbGeAlD
Ziprasidone—HTR1A—central nervous system—systemic lupus erythematosus	0.000433	0.00412	CbGeAlD
Ziprasidone—HTR7—nervous system—systemic lupus erythematosus	0.00043	0.00409	CbGeAlD
Ziprasidone—ADRA2C—lung—systemic lupus erythematosus	0.000427	0.00406	CbGeAlD
Ziprasidone—ADRA1A—nervous system—systemic lupus erythematosus	0.000415	0.00395	CbGeAlD
Ziprasidone—HTR7—central nervous system—systemic lupus erythematosus	0.000414	0.00394	CbGeAlD
Ziprasidone—HTR2A—kidney—systemic lupus erythematosus	0.000409	0.00389	CbGeAlD
Ziprasidone—DRD2—nervous system—systemic lupus erythematosus	0.000406	0.00387	CbGeAlD
Ziprasidone—KCNH2—nervous system—systemic lupus erythematosus	0.0004	0.00381	CbGeAlD
Ziprasidone—ADRA1A—central nervous system—systemic lupus erythematosus	0.000399	0.0038	CbGeAlD
Ziprasidone—ADRA2C—nervous system—systemic lupus erythematosus	0.000395	0.00376	CbGeAlD
Ziprasidone—HRH1—tendon—systemic lupus erythematosus	0.000395	0.00376	CbGeAlD
Ziprasidone—DRD2—central nervous system—systemic lupus erythematosus	0.000391	0.00372	CbGeAlD
Ziprasidone—ADRA2A—tendon—systemic lupus erythematosus	0.000388	0.00369	CbGeAlD
Ziprasidone—KCNH2—central nervous system—systemic lupus erythematosus	0.000386	0.00367	CbGeAlD
Ziprasidone—ADRA2C—central nervous system—systemic lupus erythematosus	0.00038	0.00362	CbGeAlD
Ziprasidone—CYP3A4—kidney—systemic lupus erythematosus	0.000378	0.0036	CbGeAlD
Ziprasidone—CYP2D6—kidney—systemic lupus erythematosus	0.000372	0.00354	CbGeAlD
Ziprasidone—CYP1A2—lung—systemic lupus erythematosus	0.00037	0.00352	CbGeAlD
Ziprasidone—CYP3A5—lung—systemic lupus erythematosus	0.000357	0.0034	CbGeAlD
Ziprasidone—HRH1—lung—systemic lupus erythematosus	0.000347	0.0033	CbGeAlD
Ziprasidone—ADRA2A—lung—systemic lupus erythematosus	0.00034	0.00324	CbGeAlD
Ziprasidone—HTR2A—tendon—systemic lupus erythematosus	0.00033	0.00314	CbGeAlD
Ziprasidone—HRH1—nervous system—systemic lupus erythematosus	0.000321	0.00305	CbGeAlD
Ziprasidone—ADRA2A—nervous system—systemic lupus erythematosus	0.000315	0.003	CbGeAlD
Ziprasidone—HRH1—central nervous system—systemic lupus erythematosus	0.000309	0.00294	CbGeAlD
Ziprasidone—ADRA2A—central nervous system—systemic lupus erythematosus	0.000304	0.00289	CbGeAlD
Ziprasidone—HTR2A—lung—systemic lupus erythematosus	0.000289	0.00275	CbGeAlD
Ziprasidone—HTR2A—nervous system—systemic lupus erythematosus	0.000268	0.00255	CbGeAlD
Ziprasidone—HTR2A—central nervous system—systemic lupus erythematosus	0.000258	0.00246	CbGeAlD
Ziprasidone—CYP3A4—nervous system—systemic lupus erythematosus	0.000248	0.00236	CbGeAlD
Ziprasidone—CYP2D6—nervous system—systemic lupus erythematosus	0.000244	0.00232	CbGeAlD
Ziprasidone—CYP3A4—central nervous system—systemic lupus erythematosus	0.000239	0.00227	CbGeAlD
Ziprasidone—CYP2D6—central nervous system—systemic lupus erythematosus	0.000235	0.00224	CbGeAlD
Ziprasidone—Hypertension—Dexamethasone—systemic lupus erythematosus	0.00011	0.000349	CcSEcCtD
Ziprasidone—Hypertension—Betamethasone—systemic lupus erythematosus	0.00011	0.000349	CcSEcCtD
Ziprasidone—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000109	0.000347	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000109	0.000347	CcSEcCtD
Ziprasidone—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000109	0.000345	CcSEcCtD
Ziprasidone—Myalgia—Betamethasone—systemic lupus erythematosus	0.000108	0.000344	CcSEcCtD
Ziprasidone—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000108	0.000344	CcSEcCtD
Ziprasidone—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000108	0.000344	CcSEcCtD
Ziprasidone—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000108	0.000344	CcSEcCtD
Ziprasidone—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000108	0.000343	CcSEcCtD
Ziprasidone—Anxiety—Betamethasone—systemic lupus erythematosus	0.000108	0.000343	CcSEcCtD
Ziprasidone—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000107	0.00034	CcSEcCtD
Ziprasidone—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000107	0.00034	CcSEcCtD
Ziprasidone—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000339	CcSEcCtD
Ziprasidone—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000106	0.000338	CcSEcCtD
Ziprasidone—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000106	0.000338	CcSEcCtD
Ziprasidone—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.000337	CcSEcCtD
Ziprasidone—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000106	0.000336	CcSEcCtD
Ziprasidone—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000105	0.000336	CcSEcCtD
Ziprasidone—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.000335	CcSEcCtD
Ziprasidone—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.000335	CcSEcCtD
Ziprasidone—Nausea—Leflunomide—systemic lupus erythematosus	0.000105	0.000335	CcSEcCtD
Ziprasidone—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000105	0.000334	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000105	0.000334	CcSEcCtD
Ziprasidone—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000105	0.000333	CcSEcCtD
Ziprasidone—Vision blurred—Prednisone—systemic lupus erythematosus	0.000104	0.000332	CcSEcCtD
Ziprasidone—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000104	0.000332	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000104	0.000332	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000331	CcSEcCtD
Ziprasidone—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000103	0.000329	CcSEcCtD
Ziprasidone—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000328	CcSEcCtD
Ziprasidone—Infection—Betamethasone—systemic lupus erythematosus	0.000103	0.000328	CcSEcCtD
Ziprasidone—Infection—Dexamethasone—systemic lupus erythematosus	0.000103	0.000328	CcSEcCtD
Ziprasidone—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000103	0.000327	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000102	0.000326	CcSEcCtD
Ziprasidone—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000326	CcSEcCtD
Ziprasidone—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000102	0.000326	CcSEcCtD
Ziprasidone—Anaemia—Prednisone—systemic lupus erythematosus	0.000102	0.000326	CcSEcCtD
Ziprasidone—Shock—Betamethasone—systemic lupus erythematosus	0.000102	0.000325	CcSEcCtD
Ziprasidone—Shock—Dexamethasone—systemic lupus erythematosus	0.000102	0.000325	CcSEcCtD
Ziprasidone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000102	0.000324	CcSEcCtD
Ziprasidone—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000102	0.000324	CcSEcCtD
Ziprasidone—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000102	0.000324	CcSEcCtD
Ziprasidone—Agitation—Prednisone—systemic lupus erythematosus	0.000102	0.000324	CcSEcCtD
Ziprasidone—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000102	0.000323	CcSEcCtD
Ziprasidone—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000102	0.000323	CcSEcCtD
Ziprasidone—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000101	0.000322	CcSEcCtD
Ziprasidone—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000101	0.000322	CcSEcCtD
Ziprasidone—Angioedema—Prednisone—systemic lupus erythematosus	0.000101	0.000322	CcSEcCtD
Ziprasidone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000101	0.00032	CcSEcCtD
Ziprasidone—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000101	0.00032	CcSEcCtD
Ziprasidone—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.0001	0.00032	CcSEcCtD
Ziprasidone—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.0001	0.000319	CcSEcCtD
Ziprasidone—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.0001	0.000319	CcSEcCtD
Ziprasidone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.0001	0.000318	CcSEcCtD
Ziprasidone—Vertigo—Prednisone—systemic lupus erythematosus	9.94e-05	0.000317	CcSEcCtD
Ziprasidone—Eye disorder—Methotrexate—systemic lupus erythematosus	9.93e-05	0.000316	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	9.93e-05	0.000316	CcSEcCtD
Ziprasidone—Syncope—Prednisone—systemic lupus erythematosus	9.92e-05	0.000316	CcSEcCtD
Ziprasidone—Tinnitus—Methotrexate—systemic lupus erythematosus	9.91e-05	0.000315	CcSEcCtD
Ziprasidone—Anorexia—Betamethasone—systemic lupus erythematosus	9.89e-05	0.000315	CcSEcCtD
Ziprasidone—Anorexia—Dexamethasone—systemic lupus erythematosus	9.89e-05	0.000315	CcSEcCtD
Ziprasidone—Urticaria—Prednisolone—systemic lupus erythematosus	9.87e-05	0.000314	CcSEcCtD
Ziprasidone—Cardiac disorder—Methotrexate—systemic lupus erythematosus	9.86e-05	0.000314	CcSEcCtD
Ziprasidone—Fatigue—Triamcinolone—systemic lupus erythematosus	9.85e-05	0.000314	CcSEcCtD
Ziprasidone—Fatigue—Methylprednisolone—systemic lupus erythematosus	9.83e-05	0.000313	CcSEcCtD
Ziprasidone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	9.82e-05	0.000313	CcSEcCtD
Ziprasidone—Asthenia—Cyclosporine—systemic lupus erythematosus	9.8e-05	0.000312	CcSEcCtD
Ziprasidone—Loss of consciousness—Prednisone—systemic lupus erythematosus	9.73e-05	0.00031	CcSEcCtD
Ziprasidone—Hypotension—Dexamethasone—systemic lupus erythematosus	9.69e-05	0.000309	CcSEcCtD
Ziprasidone—Hypotension—Betamethasone—systemic lupus erythematosus	9.69e-05	0.000309	CcSEcCtD
Ziprasidone—Urticaria—Hydrocortisone—systemic lupus erythematosus	9.64e-05	0.000307	CcSEcCtD
Ziprasidone—Angiopathy—Methotrexate—systemic lupus erythematosus	9.64e-05	0.000307	CcSEcCtD
Ziprasidone—Immune system disorder—Methotrexate—systemic lupus erythematosus	9.6e-05	0.000306	CcSEcCtD
Ziprasidone—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	9.6e-05	0.000305	CcSEcCtD
Ziprasidone—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	9.6e-05	0.000305	CcSEcCtD
Ziprasidone—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	9.58e-05	0.000305	CcSEcCtD
Ziprasidone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	9.56e-05	0.000304	CcSEcCtD
Ziprasidone—Hypertension—Prednisone—systemic lupus erythematosus	9.55e-05	0.000304	CcSEcCtD
Ziprasidone—Chills—Methotrexate—systemic lupus erythematosus	9.53e-05	0.000303	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	9.45e-05	0.000301	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	9.45e-05	0.000301	CcSEcCtD
Ziprasidone—Arthralgia—Prednisone—systemic lupus erythematosus	9.42e-05	0.0003	CcSEcCtD
Ziprasidone—Myalgia—Prednisone—systemic lupus erythematosus	9.42e-05	0.0003	CcSEcCtD
Ziprasidone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	9.42e-05	0.0003	CcSEcCtD
Ziprasidone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	9.4e-05	0.000299	CcSEcCtD
Ziprasidone—Anxiety—Prednisone—systemic lupus erythematosus	9.39e-05	0.000299	CcSEcCtD
Ziprasidone—Alopecia—Methotrexate—systemic lupus erythematosus	9.39e-05	0.000299	CcSEcCtD
Ziprasidone—Insomnia—Betamethasone—systemic lupus erythematosus	9.38e-05	0.000299	CcSEcCtD
Ziprasidone—Insomnia—Dexamethasone—systemic lupus erythematosus	9.38e-05	0.000299	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	9.36e-05	0.000298	CcSEcCtD
Ziprasidone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	9.35e-05	0.000298	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	9.33e-05	0.000297	CcSEcCtD
Ziprasidone—Paraesthesia—Betamethasone—systemic lupus erythematosus	9.31e-05	0.000296	CcSEcCtD
Ziprasidone—Paraesthesia—Dexamethasone—systemic lupus erythematosus	9.31e-05	0.000296	CcSEcCtD
Ziprasidone—Mental disorder—Methotrexate—systemic lupus erythematosus	9.31e-05	0.000296	CcSEcCtD
Ziprasidone—Erythema—Methotrexate—systemic lupus erythematosus	9.25e-05	0.000294	CcSEcCtD
Ziprasidone—Malnutrition—Methotrexate—systemic lupus erythematosus	9.25e-05	0.000294	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	9.16e-05	0.000292	CcSEcCtD
Ziprasidone—Dyspepsia—Dexamethasone—systemic lupus erythematosus	9.13e-05	0.000291	CcSEcCtD
Ziprasidone—Dyspepsia—Betamethasone—systemic lupus erythematosus	9.13e-05	0.000291	CcSEcCtD
Ziprasidone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	9.12e-05	0.00029	CcSEcCtD
Ziprasidone—Urticaria—Triamcinolone—systemic lupus erythematosus	9.08e-05	0.000289	CcSEcCtD
Ziprasidone—Urticaria—Methylprednisolone—systemic lupus erythematosus	9.06e-05	0.000288	CcSEcCtD
Ziprasidone—Body temperature increased—Triamcinolone—systemic lupus erythematosus	9.04e-05	0.000288	CcSEcCtD
Ziprasidone—Dizziness—Cyclosporine—systemic lupus erythematosus	9.03e-05	0.000288	CcSEcCtD
Ziprasidone—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	9.02e-05	0.000287	CcSEcCtD
Ziprasidone—Decreased appetite—Dexamethasone—systemic lupus erythematosus	9.02e-05	0.000287	CcSEcCtD
Ziprasidone—Decreased appetite—Betamethasone—systemic lupus erythematosus	9.02e-05	0.000287	CcSEcCtD
Ziprasidone—Infection—Prednisone—systemic lupus erythematosus	8.97e-05	0.000286	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	8.95e-05	0.000285	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	8.95e-05	0.000285	CcSEcCtD
Ziprasidone—Back pain—Methotrexate—systemic lupus erythematosus	8.95e-05	0.000285	CcSEcCtD
Ziprasidone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	8.94e-05	0.000285	CcSEcCtD
Ziprasidone—Fatigue—Betamethasone—systemic lupus erythematosus	8.94e-05	0.000285	CcSEcCtD
Ziprasidone—Fatigue—Dexamethasone—systemic lupus erythematosus	8.94e-05	0.000285	CcSEcCtD
Ziprasidone—Shock—Prednisone—systemic lupus erythematosus	8.89e-05	0.000283	CcSEcCtD
Ziprasidone—Nervous system disorder—Prednisone—systemic lupus erythematosus	8.86e-05	0.000282	CcSEcCtD
Ziprasidone—Tachycardia—Prednisone—systemic lupus erythematosus	8.81e-05	0.000281	CcSEcCtD
Ziprasidone—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	8.81e-05	0.000281	CcSEcCtD
Ziprasidone—Skin disorder—Prednisone—systemic lupus erythematosus	8.77e-05	0.000279	CcSEcCtD
Ziprasidone—Hyperhidrosis—Prednisone—systemic lupus erythematosus	8.73e-05	0.000278	CcSEcCtD
Ziprasidone—Vision blurred—Methotrexate—systemic lupus erythematosus	8.72e-05	0.000277	CcSEcCtD
Ziprasidone—Asthenia—Hydrocortisone—systemic lupus erythematosus	8.71e-05	0.000277	CcSEcCtD
Ziprasidone—Vomiting—Cyclosporine—systemic lupus erythematosus	8.68e-05	0.000276	CcSEcCtD
Ziprasidone—Rash—Cyclosporine—systemic lupus erythematosus	8.61e-05	0.000274	CcSEcCtD
Ziprasidone—Anorexia—Prednisone—systemic lupus erythematosus	8.61e-05	0.000274	CcSEcCtD
Ziprasidone—Dermatitis—Cyclosporine—systemic lupus erythematosus	8.6e-05	0.000274	CcSEcCtD
Ziprasidone—Headache—Cyclosporine—systemic lupus erythematosus	8.56e-05	0.000272	CcSEcCtD
Ziprasidone—Anaemia—Methotrexate—systemic lupus erythematosus	8.55e-05	0.000272	CcSEcCtD
Ziprasidone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	8.55e-05	0.000272	CcSEcCtD
Ziprasidone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	8.55e-05	0.000272	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	8.48e-05	0.00027	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	8.48e-05	0.00027	CcSEcCtD
Ziprasidone—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	8.47e-05	0.00027	CcSEcCtD
Ziprasidone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	8.42e-05	0.000268	CcSEcCtD
Ziprasidone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	8.4e-05	0.000267	CcSEcCtD
Ziprasidone—Rash—Mycophenolate mofetil—systemic lupus erythematosus	8.4e-05	0.000267	CcSEcCtD
Ziprasidone—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	8.39e-05	0.000267	CcSEcCtD
Ziprasidone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	8.35e-05	0.000266	CcSEcCtD
Ziprasidone—Vertigo—Methotrexate—systemic lupus erythematosus	8.31e-05	0.000265	CcSEcCtD
Ziprasidone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	8.31e-05	0.000264	CcSEcCtD
Ziprasidone—Leukopenia—Methotrexate—systemic lupus erythematosus	8.28e-05	0.000264	CcSEcCtD
Ziprasidone—Urticaria—Dexamethasone—systemic lupus erythematosus	8.24e-05	0.000262	CcSEcCtD
Ziprasidone—Urticaria—Betamethasone—systemic lupus erythematosus	8.24e-05	0.000262	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	8.23e-05	0.000262	CcSEcCtD
Ziprasidone—Dizziness—Prednisolone—systemic lupus erythematosus	8.22e-05	0.000262	CcSEcCtD
Ziprasidone—Asthenia—Triamcinolone—systemic lupus erythematosus	8.2e-05	0.000261	CcSEcCtD
Ziprasidone—Abdominal pain—Betamethasone—systemic lupus erythematosus	8.2e-05	0.000261	CcSEcCtD
Ziprasidone—Abdominal pain—Dexamethasone—systemic lupus erythematosus	8.2e-05	0.000261	CcSEcCtD
Ziprasidone—Body temperature increased—Dexamethasone—systemic lupus erythematosus	8.2e-05	0.000261	CcSEcCtD
Ziprasidone—Body temperature increased—Betamethasone—systemic lupus erythematosus	8.2e-05	0.000261	CcSEcCtD
Ziprasidone—Asthenia—Methylprednisolone—systemic lupus erythematosus	8.18e-05	0.00026	CcSEcCtD
Ziprasidone—Insomnia—Prednisone—systemic lupus erythematosus	8.17e-05	0.00026	CcSEcCtD
Ziprasidone—Nausea—Cyclosporine—systemic lupus erythematosus	8.11e-05	0.000258	CcSEcCtD
Ziprasidone—Paraesthesia—Prednisone—systemic lupus erythematosus	8.11e-05	0.000258	CcSEcCtD
Ziprasidone—Cough—Methotrexate—systemic lupus erythematosus	8.07e-05	0.000257	CcSEcCtD
Ziprasidone—Dizziness—Hydrocortisone—systemic lupus erythematosus	8.03e-05	0.000256	CcSEcCtD
Ziprasidone—Dyspepsia—Prednisone—systemic lupus erythematosus	7.95e-05	0.000253	CcSEcCtD
Ziprasidone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	7.91e-05	0.000252	CcSEcCtD
Ziprasidone—Chest pain—Methotrexate—systemic lupus erythematosus	7.87e-05	0.000251	CcSEcCtD
Ziprasidone—Myalgia—Methotrexate—systemic lupus erythematosus	7.87e-05	0.000251	CcSEcCtD
Ziprasidone—Arthralgia—Methotrexate—systemic lupus erythematosus	7.87e-05	0.000251	CcSEcCtD
Ziprasidone—Decreased appetite—Prednisone—systemic lupus erythematosus	7.85e-05	0.00025	CcSEcCtD
Ziprasidone—Rash—Prednisolone—systemic lupus erythematosus	7.84e-05	0.000249	CcSEcCtD
Ziprasidone—Dermatitis—Prednisolone—systemic lupus erythematosus	7.83e-05	0.000249	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	7.82e-05	0.000249	CcSEcCtD
Ziprasidone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.8e-05	0.000248	CcSEcCtD
Ziprasidone—Fatigue—Prednisone—systemic lupus erythematosus	7.79e-05	0.000248	CcSEcCtD
Ziprasidone—Headache—Prednisolone—systemic lupus erythematosus	7.79e-05	0.000248	CcSEcCtD
Ziprasidone—Constipation—Prednisone—systemic lupus erythematosus	7.72e-05	0.000246	CcSEcCtD
Ziprasidone—Vomiting—Hydrocortisone—systemic lupus erythematosus	7.72e-05	0.000246	CcSEcCtD
Ziprasidone—Rash—Hydrocortisone—systemic lupus erythematosus	7.65e-05	0.000244	CcSEcCtD
Ziprasidone—Dermatitis—Hydrocortisone—systemic lupus erythematosus	7.65e-05	0.000243	CcSEcCtD
Ziprasidone—Confusional state—Methotrexate—systemic lupus erythematosus	7.61e-05	0.000242	CcSEcCtD
Ziprasidone—Headache—Hydrocortisone—systemic lupus erythematosus	7.6e-05	0.000242	CcSEcCtD
Ziprasidone—Dizziness—Triamcinolone—systemic lupus erythematosus	7.56e-05	0.000241	CcSEcCtD
Ziprasidone—Dizziness—Methylprednisolone—systemic lupus erythematosus	7.54e-05	0.00024	CcSEcCtD
Ziprasidone—Infection—Methotrexate—systemic lupus erythematosus	7.5e-05	0.000239	CcSEcCtD
Ziprasidone—Feeling abnormal—Prednisone—systemic lupus erythematosus	7.44e-05	0.000237	CcSEcCtD
Ziprasidone—Asthenia—Betamethasone—systemic lupus erythematosus	7.44e-05	0.000237	CcSEcCtD
Ziprasidone—Asthenia—Dexamethasone—systemic lupus erythematosus	7.44e-05	0.000237	CcSEcCtD
Ziprasidone—Nervous system disorder—Methotrexate—systemic lupus erythematosus	7.4e-05	0.000236	CcSEcCtD
Ziprasidone—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	7.39e-05	0.000235	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	7.39e-05	0.000235	CcSEcCtD
Ziprasidone—Nausea—Prednisolone—systemic lupus erythematosus	7.38e-05	0.000235	CcSEcCtD
Ziprasidone—Skin disorder—Methotrexate—systemic lupus erythematosus	7.33e-05	0.000233	CcSEcCtD
Ziprasidone—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	7.3e-05	0.000232	CcSEcCtD
Ziprasidone—Vomiting—Triamcinolone—systemic lupus erythematosus	7.27e-05	0.000231	CcSEcCtD
Ziprasidone—Vomiting—Methylprednisolone—systemic lupus erythematosus	7.25e-05	0.000231	CcSEcCtD
Ziprasidone—Nausea—Hydrocortisone—systemic lupus erythematosus	7.21e-05	0.00023	CcSEcCtD
Ziprasidone—Rash—Triamcinolone—systemic lupus erythematosus	7.21e-05	0.000229	CcSEcCtD
Ziprasidone—Dermatitis—Triamcinolone—systemic lupus erythematosus	7.2e-05	0.000229	CcSEcCtD
Ziprasidone—Anorexia—Methotrexate—systemic lupus erythematosus	7.2e-05	0.000229	CcSEcCtD
Ziprasidone—Rash—Methylprednisolone—systemic lupus erythematosus	7.19e-05	0.000229	CcSEcCtD
Ziprasidone—Dermatitis—Methylprednisolone—systemic lupus erythematosus	7.18e-05	0.000229	CcSEcCtD
Ziprasidone—Urticaria—Prednisone—systemic lupus erythematosus	7.18e-05	0.000228	CcSEcCtD
Ziprasidone—Headache—Triamcinolone—systemic lupus erythematosus	7.16e-05	0.000228	CcSEcCtD
Ziprasidone—Headache—Methylprednisolone—systemic lupus erythematosus	7.14e-05	0.000227	CcSEcCtD
Ziprasidone—Abdominal pain—Prednisone—systemic lupus erythematosus	7.14e-05	0.000227	CcSEcCtD
Ziprasidone—Body temperature increased—Prednisone—systemic lupus erythematosus	7.14e-05	0.000227	CcSEcCtD
Ziprasidone—Diarrhoea—Betamethasone—systemic lupus erythematosus	7.1e-05	0.000226	CcSEcCtD
Ziprasidone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	7.1e-05	0.000226	CcSEcCtD
Ziprasidone—Hypotension—Methotrexate—systemic lupus erythematosus	7.05e-05	0.000225	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.88e-05	0.000219	CcSEcCtD
Ziprasidone—Dizziness—Dexamethasone—systemic lupus erythematosus	6.86e-05	0.000218	CcSEcCtD
Ziprasidone—Dizziness—Betamethasone—systemic lupus erythematosus	6.86e-05	0.000218	CcSEcCtD
Ziprasidone—Insomnia—Methotrexate—systemic lupus erythematosus	6.83e-05	0.000217	CcSEcCtD
Ziprasidone—Nausea—Triamcinolone—systemic lupus erythematosus	6.79e-05	0.000216	CcSEcCtD
Ziprasidone—Paraesthesia—Methotrexate—systemic lupus erythematosus	6.78e-05	0.000216	CcSEcCtD
Ziprasidone—Nausea—Methylprednisolone—systemic lupus erythematosus	6.77e-05	0.000216	CcSEcCtD
Ziprasidone—Dyspnoea—Methotrexate—systemic lupus erythematosus	6.73e-05	0.000214	CcSEcCtD
Ziprasidone—Somnolence—Methotrexate—systemic lupus erythematosus	6.71e-05	0.000214	CcSEcCtD
Ziprasidone—Hypersensitivity—Prednisone—systemic lupus erythematosus	6.65e-05	0.000212	CcSEcCtD
Ziprasidone—Dyspepsia—Methotrexate—systemic lupus erythematosus	6.64e-05	0.000212	CcSEcCtD
Ziprasidone—Vomiting—Dexamethasone—systemic lupus erythematosus	6.59e-05	0.00021	CcSEcCtD
Ziprasidone—Vomiting—Betamethasone—systemic lupus erythematosus	6.59e-05	0.00021	CcSEcCtD
Ziprasidone—Decreased appetite—Methotrexate—systemic lupus erythematosus	6.56e-05	0.000209	CcSEcCtD
Ziprasidone—Rash—Dexamethasone—systemic lupus erythematosus	6.54e-05	0.000208	CcSEcCtD
Ziprasidone—Rash—Betamethasone—systemic lupus erythematosus	6.54e-05	0.000208	CcSEcCtD
Ziprasidone—Dermatitis—Dexamethasone—systemic lupus erythematosus	6.53e-05	0.000208	CcSEcCtD
Ziprasidone—Dermatitis—Betamethasone—systemic lupus erythematosus	6.53e-05	0.000208	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	6.52e-05	0.000207	CcSEcCtD
Ziprasidone—Fatigue—Methotrexate—systemic lupus erythematosus	6.51e-05	0.000207	CcSEcCtD
Ziprasidone—Headache—Dexamethasone—systemic lupus erythematosus	6.5e-05	0.000207	CcSEcCtD
Ziprasidone—Headache—Betamethasone—systemic lupus erythematosus	6.5e-05	0.000207	CcSEcCtD
Ziprasidone—Asthenia—Prednisone—systemic lupus erythematosus	6.48e-05	0.000206	CcSEcCtD
Ziprasidone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	6.22e-05	0.000198	CcSEcCtD
Ziprasidone—Diarrhoea—Prednisone—systemic lupus erythematosus	6.18e-05	0.000197	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	6.17e-05	0.000197	CcSEcCtD
Ziprasidone—Nausea—Betamethasone—systemic lupus erythematosus	6.16e-05	0.000196	CcSEcCtD
Ziprasidone—Nausea—Dexamethasone—systemic lupus erythematosus	6.16e-05	0.000196	CcSEcCtD
Ziprasidone—Urticaria—Methotrexate—systemic lupus erythematosus	6e-05	0.000191	CcSEcCtD
Ziprasidone—Dizziness—Prednisone—systemic lupus erythematosus	5.97e-05	0.00019	CcSEcCtD
Ziprasidone—Body temperature increased—Methotrexate—systemic lupus erythematosus	5.97e-05	0.00019	CcSEcCtD
Ziprasidone—Abdominal pain—Methotrexate—systemic lupus erythematosus	5.97e-05	0.00019	CcSEcCtD
Ziprasidone—Vomiting—Prednisone—systemic lupus erythematosus	5.74e-05	0.000183	CcSEcCtD
Ziprasidone—Rash—Prednisone—systemic lupus erythematosus	5.69e-05	0.000181	CcSEcCtD
Ziprasidone—Dermatitis—Prednisone—systemic lupus erythematosus	5.69e-05	0.000181	CcSEcCtD
Ziprasidone—Headache—Prednisone—systemic lupus erythematosus	5.66e-05	0.00018	CcSEcCtD
Ziprasidone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.56e-05	0.000177	CcSEcCtD
Ziprasidone—Asthenia—Methotrexate—systemic lupus erythematosus	5.42e-05	0.000172	CcSEcCtD
Ziprasidone—Nausea—Prednisone—systemic lupus erythematosus	5.36e-05	0.000171	CcSEcCtD
Ziprasidone—Diarrhoea—Methotrexate—systemic lupus erythematosus	5.16e-05	0.000164	CcSEcCtD
Ziprasidone—Dizziness—Methotrexate—systemic lupus erythematosus	4.99e-05	0.000159	CcSEcCtD
Ziprasidone—Vomiting—Methotrexate—systemic lupus erythematosus	4.8e-05	0.000153	CcSEcCtD
Ziprasidone—Rash—Methotrexate—systemic lupus erythematosus	4.76e-05	0.000152	CcSEcCtD
Ziprasidone—Dermatitis—Methotrexate—systemic lupus erythematosus	4.75e-05	0.000151	CcSEcCtD
Ziprasidone—Headache—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000151	CcSEcCtD
Ziprasidone—Nausea—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000143	CcSEcCtD
Ziprasidone—CHRM5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.85e-06	8.59e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	5.84e-06	8.58e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—MMP9—systemic lupus erythematosus	5.82e-06	8.56e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.8e-06	8.53e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	5.77e-06	8.47e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	5.75e-06	8.45e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CD80—systemic lupus erythematosus	5.74e-06	8.43e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—MMP9—systemic lupus erythematosus	5.73e-06	8.42e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	5.73e-06	8.42e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL2—systemic lupus erythematosus	5.72e-06	8.41e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CD80—systemic lupus erythematosus	5.72e-06	8.4e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.71e-06	8.39e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—IL6—systemic lupus erythematosus	5.69e-06	8.36e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	5.68e-06	8.35e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—EP300—systemic lupus erythematosus	5.68e-06	8.34e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—NOS3—systemic lupus erythematosus	5.67e-06	8.32e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	5.66e-06	8.32e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—MMP9—systemic lupus erythematosus	5.65e-06	8.31e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	5.65e-06	8.3e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	5.64e-06	8.29e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	5.63e-06	8.28e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.63e-06	8.28e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	5.61e-06	8.24e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.57e-06	8.19e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	5.54e-06	8.14e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	5.53e-06	8.13e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	5.52e-06	8.11e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	5.5e-06	8.08e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.5e-06	8.08e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	5.47e-06	8.04e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	5.45e-06	8.01e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	5.45e-06	8.01e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—IL6—systemic lupus erythematosus	5.45e-06	8.01e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	5.45e-06	8e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	5.43e-06	7.99e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	5.43e-06	7.98e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	5.42e-06	7.97e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	5.41e-06	7.96e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.4e-06	7.93e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.38e-06	7.91e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	5.38e-06	7.9e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.38e-06	7.9e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	5.37e-06	7.88e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—EP300—systemic lupus erythematosus	5.36e-06	7.88e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.36e-06	7.88e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	5.35e-06	7.86e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	5.35e-06	7.86e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.35e-06	7.86e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.34e-06	7.85e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.33e-06	7.83e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCL2—systemic lupus erythematosus	5.31e-06	7.81e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.28e-06	7.76e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	5.27e-06	7.74e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	5.26e-06	7.73e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.25e-06	7.71e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	5.25e-06	7.71e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.23e-06	7.69e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	5.2e-06	7.64e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—systemic lupus erythematosus	5.18e-06	7.61e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	5.16e-06	7.58e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.15e-06	7.56e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.14e-06	7.55e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—EP300—systemic lupus erythematosus	5.13e-06	7.54e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	5.09e-06	7.48e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.08e-06	7.46e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.07e-06	7.45e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	5.01e-06	7.37e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	4.98e-06	7.32e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.96e-06	7.29e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.95e-06	7.27e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.94e-06	7.26e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.93e-06	7.25e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.9e-06	7.2e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.9e-06	7.2e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	4.89e-06	7.19e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	4.88e-06	7.17e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	4.87e-06	7.15e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.87e-06	7.15e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.86e-06	7.14e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.86e-06	7.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	4.86e-06	7.14e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.86e-06	7.13e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	4.84e-06	7.11e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	4.83e-06	7.1e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	4.83e-06	7.09e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TYK2—systemic lupus erythematosus	4.83e-06	7.09e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—IL6—systemic lupus erythematosus	4.82e-06	7.09e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.8e-06	7.05e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.79e-06	7.04e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.78e-06	7.02e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.78e-06	7.02e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.77e-06	7.01e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.77e-06	7e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.77e-06	7e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	4.76e-06	7e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	4.75e-06	6.99e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.75e-06	6.98e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—NOS3—systemic lupus erythematosus	4.74e-06	6.96e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.72e-06	6.94e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.69e-06	6.89e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	4.69e-06	6.89e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.68e-06	6.87e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.66e-06	6.85e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	4.66e-06	6.85e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.66e-06	6.85e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.64e-06	6.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.64e-06	6.81e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.63e-06	6.81e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.6e-06	6.75e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.58e-06	6.73e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.57e-06	6.72e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.56e-06	6.7e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	4.54e-06	6.67e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.51e-06	6.63e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	4.46e-06	6.56e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.46e-06	6.56e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	4.44e-06	6.53e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.44e-06	6.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.43e-06	6.51e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.42e-06	6.5e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.41e-06	6.49e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.4e-06	6.46e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	4.36e-06	6.4e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	4.36e-06	6.4e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.35e-06	6.39e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—EP300—systemic lupus erythematosus	4.31e-06	6.33e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.29e-06	6.31e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.28e-06	6.29e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.25e-06	6.25e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.23e-06	6.21e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.21e-06	6.19e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	4.21e-06	6.18e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.21e-06	6.18e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.2e-06	6.17e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	4.19e-06	6.15e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.14e-06	6.08e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.13e-06	6.07e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.13e-06	6.06e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.12e-06	6.05e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	4.12e-06	6.05e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.1e-06	6.03e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	4.1e-06	6.02e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.08e-06	5.99e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	4.07e-06	5.98e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.06e-06	5.97e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.05e-06	5.95e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	4.05e-06	5.95e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	4.04e-06	5.94e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.03e-06	5.92e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	4.03e-06	5.92e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.02e-06	5.91e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL2—systemic lupus erythematosus	4.02e-06	5.9e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.01e-06	5.89e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	4.01e-06	5.89e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—systemic lupus erythematosus	4e-06	5.87e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.98e-06	5.85e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	3.98e-06	5.84e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	3.97e-06	5.83e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.96e-06	5.82e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	3.96e-06	5.81e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	3.95e-06	5.81e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.95e-06	5.8e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	3.94e-06	5.79e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.9e-06	5.72e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.88e-06	5.7e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.86e-06	5.66e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.83e-06	5.63e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.82e-06	5.62e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.82e-06	5.61e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.81e-06	5.6e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.81e-06	5.6e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.8e-06	5.58e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.8e-06	5.58e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.79e-06	5.58e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.79e-06	5.57e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.79e-06	5.56e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.77e-06	5.53e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.76e-06	5.53e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.75e-06	5.51e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.75e-06	5.51e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.74e-06	5.5e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	3.72e-06	5.47e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—systemic lupus erythematosus	3.72e-06	5.46e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	3.69e-06	5.43e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	3.69e-06	5.43e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	3.68e-06	5.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.67e-06	5.39e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.66e-06	5.37e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.64e-06	5.35e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.63e-06	5.34e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	3.63e-06	5.33e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	3.62e-06	5.32e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	3.62e-06	5.32e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	3.61e-06	5.31e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EP300—systemic lupus erythematosus	3.6e-06	5.29e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	3.57e-06	5.24e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	3.56e-06	5.23e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	3.56e-06	5.23e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.54e-06	5.2e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.54e-06	5.2e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—systemic lupus erythematosus	3.51e-06	5.16e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.5e-06	5.14e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.49e-06	5.12e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.48e-06	5.12e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.47e-06	5.11e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.44e-06	5.06e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.43e-06	5.05e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.42e-06	5.03e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.41e-06	5.01e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3.39e-06	4.98e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.38e-06	4.97e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.37e-06	4.95e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—systemic lupus erythematosus	3.36e-06	4.94e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.34e-06	4.9e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.31e-06	4.86e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.21e-06	4.72e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	3.2e-06	4.71e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	3.16e-06	4.65e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.16e-06	4.64e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.15e-06	4.63e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.14e-06	4.62e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.13e-06	4.6e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.13e-06	4.6e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.1e-06	4.56e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	3.1e-06	4.55e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.09e-06	4.55e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	3e-06	4.41e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.87e-06	4.22e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.87e-06	4.22e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	2.85e-06	4.19e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.76e-06	4.05e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.74e-06	4.03e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.67e-06	3.92e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.62e-06	3.86e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.62e-06	3.86e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.58e-06	3.79e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.57e-06	3.78e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	2.42e-06	3.55e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.38e-06	3.5e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	2.38e-06	3.49e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	2.37e-06	3.48e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—systemic lupus erythematosus	2.36e-06	3.47e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	2.34e-06	3.43e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.33e-06	3.43e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.32e-06	3.4e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.21e-06	3.25e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.18e-06	3.21e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.17e-06	3.18e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.03e-06	2.98e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.68e-06	2.48e-05	CbGpPWpGaD
